Emergence of Covid-19 to Boost Adoption of Protein Assays Market to Detect Antibodies against Various Proteins of Coronavirus

 

The Bradford protein assay is used extensively for analysis of proteins in many applications including drug discovery, food safety, and medical diagnostics. The assays are also useful in the analysis of various proteins complexes that have been detected by various methods. The concept of this assay is based on the interaction of protein molecules with fluorescent dye under acidic conditions resulting in a bluish color shift from blue to red. This process actually determines the presence of all the basic amino acids, arginine, glycine and histidine that leads to formation of the co-enzymatic protein complex. It can be used in combination with other methods for evaluation of protein content.

Market Insights

Significant growth in the pharmaceutical sector is expected to propel growth of the global protein assays market. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe invested US$ 19, 509 million in 2000, which increased to US$ 39,895 million (est.) in 2018. Moreover, launch of graphene-based electrochemical biosensors is also expected to aid in growth of the market. For instance, in February 2018, Nanomedical Diagnostics launched Graphene Biosensor- FLEX, which can be easily integrated with company’s Agile R100 protein assay system to increase the efficiency of the drug discovery process.

Among regions, Europe is expected to witness significant growth in the protein assays market, owing to growing pharmaceutical sector. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe was valued at US$ 139, 287 million in 2000, which increased to US$ 284, 028 million (est.) in 2018.

Emergence of Covid-19 is expected to boost adoption of protein assays to detect antibodies against various proteins of coronavirus. For instance, in August 2020, Eurofins launched multiple serological assay solutions to detect antibodies targeted against the Nucleocapsid protein of the novel coronavirus.

Competitive Analysis

Major players operating in the global Protein Assays Market include, Thermo Fisher Scientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories, Inc., Lonza Group, Abcam plc, PerkinElmer Inc., Bio-Techne, BioVision Inc., Eurofins, AYOXXA Biosystems GmbH, Cell Signaling Technology, Inc., and Geno Technology Inc.

January 2019: AYOXXA Biosystems GmbH signed a research agreement with one of the leading pharmaceutical companies (details were not disclosed) for the development of a series of low volume, high sensitivity multiplex protein assays intend to validate protein biomarkers in the field of ophthalmology.